newdrugapprovals.org
Lorlatinib, лорлатиниб , لورلاتينيب , 洛拉替尼 , PF-6463922
Lorlatinib, PF-6463922 For Cancer; Non-small-cell lung cancer Molecular Formula C21H19FN6O2 Average mass 406.413 Da Phase 2 WO 2013132376 Andrew James Jensen, Suman Luthra, Paul Francis RICHARDSON …